Can this injection regrow knee cartilage?

NCT ID NCT05816395

First seen Feb 23, 2026 · Last updated May 15, 2026 · Updated 13 times

Summary

This study tested an experimental drug called RHH646 in 82 adults with knee osteoarthritis. The goal was to see if the drug could help regrow cartilage in the knee and check for any side effects. Participants received either the drug or a placebo, and changes in cartilage were measured using MRI scans.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS, KNEE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Clinical Trial Network

    Houston, Texas, 77074, United States

  • Clinical Trials Research

    Lincoln, California, 95648, United States

  • Conquest Research

    Winter Park, Florida, 32789, United States

  • Novartis Investigative Site

    Buenos Aires, C1055AAF, Argentina

  • Novartis Investigative Site

    Caba, C1015ABO, Argentina

  • Novartis Investigative Site

    Gandrup, 9362, Denmark

  • Novartis Investigative Site

    Herlev, 2730, Denmark

  • Novartis Investigative Site

    Warsaw, 00-874, Poland

  • Novartis Investigative Site

    Santiago, A Coruna, 15705, Spain

  • Pioneer Research Solutions

    Sugar Land, Texas, 77479, United States

Conditions

Explore the condition pages connected to this study.